Concepedia
Statistics
Publications
7
Citations
426
H-Index
Active since
2003
Affiliations
University Hospital Regensburg(Current)
University of Regensburg
Universitätsklinikum Erlangen
Universität Hamburg
University Hospital Bonn
Anna Berand is an author at University Hospital Regensburg specializing in medicine, oncology, and urology.
Top concepts
MedicineOncologyUrologyPharmacologyCancer TherapyCancer ResearchTumor MicroenvironmentPathologyDermatologyClinical Trials
Publications per year
2003–2011
Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumors
Thomas Vogt, Christian Hafner, K. Bross et al. · Cancer · 2003 · 143 citations
Pioglitazone and rofecoxib combined with angiostatically scheduled trofosfamide in the treatment of far‐advanced melanoma and soft tissue sarcoma
Albrecht Reichle, K. Bross, Thomas Vogt et al. · Cancer · 2004 · 99 citations
Targeted combined anti-inflammatory and angiostatic therapy in advanced melanoma: a randomized phase II trial
Albrecht Reichle, Thomas Vogt, Brigitte Coras et al. · Melanoma Research · 2007 · 56 citations
Pharmacotherapy, Metronomic Chemotherapy, Dermatology +18
Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant Melanoma
Stefanie Meyer, Thomas Vogt, Michael Landthaler et al. · PPAR Research · 2009 · 56 citations · Full text
Malignant Disease, Cox2 Expression, Medicine +15
Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial
Bernhard Walter, Irmela Schrettenbrunner, Martin Vogelhuber et al. · Medical Oncology · 2011 · 30 citations
Urology, Oncology, Genitourinary Cancer +7
1–5 of 7